MartinS.RheeMD
Internal Medicine • Brockton, MAInfectious Disease
Assistant Professor, Medicine, Tufts Medical Center
Are you Dr. Rhee?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 7 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
680 Centre St
Brockton, MA 02302Phone+1 508-941-7000Fax+1 508-941-6337- Is this information wrong?
Summary
- Dr. Martin Rhee, MD is an internist in Brockton, Massachusetts. He is an Assistant Professor at Tufts Medical Center.
Education & Training
Tufts Medical CenterFellowship, Infectious Disease, 2004 - 2008
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2000 - 2003
Seoul National University College of MedicineClass of 1998
Clinical Trials
- Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz. Start of enrollment: 2000 Mar 01
- Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection Start of enrollment: 2007 Feb 01
- Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults Start of enrollment: 2010 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 24 citationsAbsence of Lenacapavir (GS-6207) Phenotypic Resistance in HIV Gag Cleavage Site Mutants and in Isolates with Resistance to Existing Drug Classes.Nicolas A. Margot, Renee Ram, Martin S. Rhee, Christian Callebaut> ;Antimicrobial Agents and Chemotherapy. 2021 Feb 17
- 156 citationsClinical targeting of HIV capsid protein with a long-acting small molecule.John O. Link, Martin S. Rhee, Tse Winston C, Jim Zheng, John R. Somoza, William Rowe, Rebecca Begley, Anna Chiu, Andrew Mulato, Derek Hansen, Eric Singer, Luong K. Tsa...> ;Nature. 2020 Jul 1
- 21 citationsTenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, a...Alan Winston, Frank A. Post, Edwin DeJesus, Daniel Podzamczer, Giovanni Di Perri, Vicente Estrada, François Raffi, Peter Ruane, Paula Peyrani, Gordon Crofoot, Patrick ...> ;The Lancet. HIV. 2018 Apr 1
- Join now to see all
Press Mentions
Experimental HIV Drug Seems Effective at a Twice-a-year Dose, Study FindsJuly 1st, 2020- An HIV Drug You Only Take Twice a Year?July 1st, 2020
